CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reaches Milestone in Human Clinical Study, Notes Growing Availability of DehydraTECH-Enabled Products

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reached a significant point in its second human clinical study of 2021: HYPER-H21-2. The company announced that dosing has been completed in the study, which was comprised of 16 human volunteers who were pre- or mildly hypertensive; each participant received three separate doses of 150 mg each of DehydraTECH(TM) 2.0-enabled CBD versus a placebo. The study also included 24-hour continuous monitoring of blood pressure and heart rate, as well as evaluations of central arterial stiffness, physical activity and sleep quality. This key information will be assessed to evaluate the human response to DehydraTECH 2.0-enabled CBD. The company anticipates beginning a third human clinical study, HYPER-H21-3, following analysis of results from the first and second studies. In addition, Lexaria announced the expansion of its intellectual property portfolio with the allowance of its second patent in Japan. The patent is the 21st patent the company has been granted. Lexaria also noted that more than 7,000 stores across the country sell products that use its exclusive DehydraTECH technology. Some of those products include Cannadips, the original tobacco-free and nicotine-free CBD pouch; a growing number of New World CBD SKUs; and next-generation CHYLOSOMA(TM) formulations of CBD, CBG and CBN topical skin offerings. “Lexaria’s technology is enabling increased market share and sales growth for our continually growing list of corporate clients,” said Lexaria CEO Chris Bunka. “We are delighted to help these innovators of today and leaders of tomorrow offer their clients superior performance and experiences that competitors simply cannot match, and we are highly anticipatory of additional growth to come.”

To view the full press releases, visit https://cnw.fm/mM3a5 and https://cnw.fm/IwTRR

About Lexaria Bioscience Corp.

Lexaria Bioscience’s proprietary drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The company’s technology can be applied to many different ingestible product formats including foods, beverages, oral suspensions, tablets and capsules. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption of cannabinoids and nicotine by up to 5 to 10 times, reduce time of onset from one to two hours to minutes, and mask unwanted tastes; the technology is planned to be further evaluated for orally administered bioactive molecules including anti-viral drugs, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs) and more. Lexaria has licensed DehydraTECH to multiple companies including a world-leading tobacco producer for the development of smokeless, oral-based nicotine products and for use in industries that produce cannabinoid beverages, edibles and oral products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit http://www.LexariaBioScience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — California Launches Cannabis Agency to Ease Industry Regulation

America’s state legal cannabis sector has seen major growth in the past few years as more states have legalized cannabis. California, which legalized recreational marijuana five years ago, has since sold $4.4 billion worth of cannabis, making its cannabis sector one of, if not the most, successful cannabis markets in America. Now in a move that is meant to simplify how California regulates its massive and swiftly growing cannabis space, Governor Gavin Newsom has signed a law creating a single agency to regulate cannabis.

The policy, which Newsom first proposed in January 2020, will consolidate licensing authority from the three departments responsible for regulating California’s cannabis space: the Manufactured Cannabis Safety Branch under the Department of Health, the Bureau of Cannabis Control under the Department of Consumer Affairs, and CalCannabis under the Department of Food and Agriculture. Under the new law, a single Department of Cannabis Control will now handle the licensing, enforcement and environmental oversight duties that these three department were previously tasked with.

According to the budget summary for Newsom’s 2020–2021 budget plan where he introduced the new policy, a single department for cannabis regulation that would “centralize and align critical regulatory functions.” Additionally, it would create a single point of contact for individuals within the cannabis space as well as local governments rather than three different departments. The Department of Cannabis Control (“DCC”), which is under the Business, Consumer Services and Housing Agency, will also be in charge of California’s track and trace system, which follows cannabis and cannabis products through the state’s legal supply chain.

Lindsey Robison, executive director of the California Cannabis Industry Association, which represents more than 400 licensed cannabis enterprises, has applauded the new law. She says navigating three agencies with different protocols and processes has often been a bone of contention for many cannabis businesses, and having all their functions housed under a single agency will help with communication, transparency and, hopefully, process times for applications.

According to the acting deputy director of the DCC Christina Dempsey, Newsom’s administration wants to make the legal market more attractive than the illicit market. Despite having one of the largest cannabis industries in the country, California is still plagued by the cannabis black market. Not only do illegal cannabis grows deprive the state of tax revenue, but they also steal tons of water and electricity and are responsible for violence, forced labor and the destruction of the ecosystem.

Employees of the three agencies will continue using their offices until further notice. In addition, because existing licenses will be transferred to the DCC, cannabis businesses will not need to apply for new licenses until existing licenses expire. Furthermore, law enforcement and local government will continue working with their existing contacts, and policies for grant funding for researchers will remain the same. The Department of Cannabis Control will reside at 2920 Kilgore Road in Rancho Cordova.

It remains to be seen how the new agency will make it easier for cannabis companies in California, such as Grapefruit USA Inc. (OTCQB: GPFT), to interact with regulators and comply with all the existing laws governing the industry.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Finds That Cannabis Legalization Boosts Home Property Values

Research conducted by Clever Real Estate has found that the presence of marijuana dispensaries and the legalization of marijuana helps grow home property values. The real estate service company used data from the U.S. Census and Zillow, as well as other sources for the study, which discovered that between 2017 and 2019, the value of homes increased by more than $6,000 in states where cannabis is legal in some form. This is in comparison to home values in states that haven’t legalized cannabis.

The increase in value may be driven by the tax revenues generated from the regulation and legalization of marijuana. The company found that this revenue was commonly invested into things such as infrastructure and public services, which significantly increased property value. According to the research, home values grew by nearly $500 for every $1 million in additional tax revenue generated from the sale of cannabis.

For instance, the state of Illinois sold nearly $670 million in marijuana and generated more than $200 million in tax revenue in 2020. This revenue was allocated to different causes, including the support of organizations that work to reduce street violence. Decreasing violence in communities is a good way to drive up property value. The study also discovered that states that legalized adult-use marijuana saw the highest increases in property value.

In its report, the company stated that in comparison with states where cannabis is limited to medicinal use or is still illegal, property values in states where recreational cannabis is legal rose by roughly $17,000 in the period between April 2017 and April 2021. It added that in states where legal sales are yet to begin but legalization has been enacted, property values are expected to rise by an average of $61,000.

The company notes that the presence of marijuana dispensaries seems to correspond to the increase in home property value, with findings showing that home values grew by more than $22,000 more in regions with recreational dispensaries. An analysis conducted by economists from the University of Oklahoma in 2020 also discovered that states that legalized cannabis saw increments in housing prices, with retail outlets opening for business driving this up further.

The researchers noted that this showed that the existence of dispensaries, coupled with the benefits of additional tax revenue drove the increments in price, arguing that the cannabis dispensaries were viewed as commercial amenities that the general public deemed to be valuable and/or important.

Furthermore, companies that sell cannabinoid products, such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), employ lots of people — and that alone creates more demand for homes, therefore hiking property values as those employees seek to buy houses in the vicinity.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Q1 2021 Financial Results

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced its 2021 first quarter financial results and subsequent events. “This was another great quarter for the company as we continued to see strong traction for our brands,” said Brad Rogers, RWB’s chairman & CEO. “We are building on that momentum and working towards finalizing our revised asset purchase of our Michigan investee to bring their revenue, as well as adjusted sales into IFRS revenue format before the end of this current quarter. Once complete, and the expansion of our Florida operations come on stream, we can finally report in our quarterly results the strength of what we have built and accomplished thus far.”

To view the full press release, visit https://cnw.fm/egQMZ

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Creating Brand Loyalty by ‘Doing It Right’

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leader in the health and wellness cannabidiol (“CBD”) industry, has made compliance with regulatory standards for hemp-derived products worldwide one of its main priorities. This has opened doors to outlets for its products while many other CBD companies have struggled. In a June 29 Hemp Barons podcast, HempFusion co-founder and CEO Jason Mitchell and host Joy Beckerman extensively discussed the regulatory journey CBD dietary supplements, as well as OTC cosmetic topicals, have taken under guidance from the U.S. federal government. A recent article quotes Mitchel as saying, “The fact is, it’s really fun to do it right, because it’s challenging. And then when you see the consumer response that they get the result they want, and that you did it correctly . . . they’re going to have a tremendous amount of trust in you and have longevity in their support of your brand . . . and so that’s why we did it. We create this brand loyalty by virtue of doing it right.”

To view the full article, visit https://cnw.fm/x3zgH

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 U.S. states and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs, including tinctures, proprietary FDA Drug-listed over-the-counter (“OTC”) topicals, doctor/practitioner lines, and more. With a strong focus on R&D, HempFusion has an additional 30 products under development. HempFusion is a board member of the U.S. Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in-store or by visiting HempFusion online at www.Hempfusion.com or www.Probulin.com.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://cnw.fm/CBDHF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Is Frontrunner in Search for Elusive Prize

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) is well equipped to pursue – and achieve – the quest for consistency and customization that offers value for money to recreational cannabis users. “The company’s unique partnership with Phenome One, recognized as one of Canada’s largest live genetic libraries, allows Pac Roots to focus on selective breeding and preservation,” reads a recent article. “That key partnership, which enables Pac Roots to optimize the genetic makeup of its cannabis plants as well as develop unique strains featuring a variety of beneficial characteristics, established the company as a frontrunner in the search for what the New York Times called an elusive prize: ‘a predictable, reliable product.’ With Phenome One in its corner, along with existing infrastructure, equipment and access to land as well as aligned brands, Pac Roots is ideally positioned to preserve the excellence of its elite strains while also introducing the highest quality strains.”

To view the full article, visit https://cnw.fm/zVJ9E

About Pac Roots Cannabis Corp.

Pac Roots is the future of genetics. By focusing on elite cannabis genetic development, the company maximizes the quality of its products by keeping yields and profit margins high. Pac Roots subsidizes costs with several strategic partners: Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars, as well as its JV partnership with Rock Creek Farms and Speakeasy Cannabis Club, leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within their first year of trading. For more information about the company, visit www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names New Senior VP of Global Sales and Business Development

Green Hygienics (OTCQB: GRYN) has appointed a new senior vice president. David Racz, a seasoned pharmaceutical executive, has been named senior VP of global sales and business development for the innovative, tech-driven company. Racz has garnered extensive experience in the both the pharma and cannabis sectors, having served in global, senior-level positions with well-known pharmaceutical companies including Pfizer, GlaxoSmithKline and Novartis. At Pfizer, he was vice president of sales and human resources, overseeing the largest expansion in Pfizer’s sales force in history. At SmithKline Beecham, he managed more than 4,000 sales, marketing and R&D employees, who were located in 20 countries throughout Asia, Latin America, Australia, and South Africa. He was also a member of the team that coordinated and managed the transcontinental merger of SmithKline and Beecham. At Novartis, he supervised strategy and resource allocation for the $8 billion health-care company and managed 14,000 global employees. He entered the cannabis market in 2008 when he worked with legislative bodies in Colorado to develop the state’s medical cannabis laws, and starting in 2011, he led a team that applied for and acquired six cannabinoid-related patents, discovered two cannabis chemical structures, built a cannabis DNA library with more than 4,000 different strains and oversaw the early advancement of cannabis genetic engineering for application in large-scale production.

To view the full press release, visit https://cnw.fm/MRPHi

About Green Hygienics Holdings Inc.

Green Hygienics is a California-based innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with consumer packaged goods (“CPG”) and pharmaceutical companies. For more information about the company, visit www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Partner with Avaria to Bring Award-Winning KaLaya Brand to LATAM Distribution Network

Flora Growth Corp. (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into a non-binding letter of intent (“LOI”) to form a joint venture (“JV”) with Avaria Inc. Canadian-based Avaria is the manufacturer and owner of KaLaya — an award-winning pain cream distributed across Canada. Through the JV, Flora Growth will manage registration, sales and distribution of KaLaya products in Colombia, Mexico, and other LATAM countries, while Avaria will supply finished product. Flora Growth and Avaria will equally divide the profits from the sale of KaLaya products under the JV, increasing the value of Flora’s existing distribution channels. “We are very excited to partner with Avaria to bring their established, award-winning KaLaya brand to our LATAM distribution network. We believe the product will receive a similarly strong reception as it has in Canada,” said Flora Growth CEO and President Luis Merchan. “Moving forward, Flora Lab will work with the Avaria team to produce CBD-infused versions of KaLaya products for distribution across LATAM as well as export into the United States. Given CBD’s association with wellness, KaLaya’s established formulation, and Flora Growth’s low-cost high-quality cannabis, this is a natural partnership we are excited to bring globally.”

To view the full press release, visit https://cnw.fm/vgKPw

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Shares Insta Message from ELove: ‘Best Thing on the Market’

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, and its flagship product, Hourglass THC+CBD Patchless Patch Topical Cream, has received an Instagram endorsement from Grammy Award-winning writer, producer and director Damien Matthias, known as ELove. ELove has performed and co-produced with LL Cool J, one of Def Jams Records’ first artists. He also played a key role in launching the careers of Tupac Shakur and John Forte of the Fugees and was integrally involved in the pre-internet marketing team of Def Jam Records, one of the most successful independent labels of all time. “Hourglass, the best thing on the market. You have any kind of discomfort, this right here is filled with CBD, and it actually works. Best thing on the market, no doubt,” said ELove in the Instagram post.

To view the full message, visit https://cnw.fm/tLidf

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — US Surgeon General Calls for End to Marijuana-Related Incarcerations

The war on drugs, which was launched with the noble aim of curbing drug use and defunding criminal enterprises behind the illicit drug trade, is an unmitigated failure. Tens of millions of people have been arrested and incarcerated over the past four decades, breaking up families, ruining lives and leaving the United States with the largest prison population in the world. Minorities, specifically communities of color, bore the brunt of the drug war, and they are still victim to intense policing and harsh sentencing due to drug policies.

Drug reform activists have long been advocating for the end of cannabis-related incarcerations, especially as more states have legalized either medical or recreational cannabis, and the U.S. Surgeon General is of the same opinion. Surgeon General Dr. Vivek Murthy, while talking about a federal marijuana legalization bill circulated by Senate Majority Leader Chuck Schumer, said that it is time America stops imprisoning people for cannabis use. While he didn’t endorse broad commercial legalization, he emphasized that there is no value behind incarcerating individuals for cannabis possession, stating that he thinks it doesn’t “serve anybody well.”

Taking a more neutral stance on cannabis, he pointed out that it has pros and cons, although the hype seems to have outpaced the science. The country will have to let the science guide its efforts towards decriminalizing and legalizing marijuana, he says. While the controversial drug has medicinal properties, it also has potential harms that have to be considered, and putting these two perspectives together will help inform policymakers.

Back in 2015, Murthy, who also served as Surgeon General under former President Barack Obama, pointed out that preliminary evidence showed that cannabis can be helpful against certain medical conditions and symptoms.

However, he later stated in 2018 that the wave of cannabis legalization reform sweeping across America concerned him, especially given how little remains unknown know about marijuana’s effects. The industry has grown a great deal in just a few years, and sellers have taken to making false claims about what their products can do to boost sales. In fact, the FDA has had to send warning letters to several companies to curb this false advertising.

With more states legalizing cannabis, researchers have been able to look into cannabis’ capabilities and its side effects better than ever before. President Joseph Biden, who ran his campaign on cannabis decriminalization among other issues, supports incremental decriminalization and expunging prior cannabis-related infractions from records. However, he still hasn’t acted on these promises since he took office, choosing instead to work on a massive $1.5 trillion infrastructure bill.

The views expressed by the U.S. Surgeon General regarding the futility of sending people to jail because they consume cannabis was realized years back by other countries, including Canada, where a legal marijuana market that gave companies such as Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) space to thrive was created.

NOTE TO INVESTORS: The latest news and updates relating to Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are available in the company’s newsroom at http://cnw.fm/PACR

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.